Relmada Therapeutics Inc (RLMD) Live Stock Price, Forecast & News

Relmada Therapeutics Inc
RLMD
(Nasdaq - US)
Closed
4.00
-0.30 (-6.98%)
in:usd•As of: Apr 19, 2024 15:59 UTC -4
Open
4.28
High
4.28
Low
3.95

Stats
Prev. Close
4.30
Open
4.28
Day's Range
3.95 - 4.28
52 Week Range
2.36 - 7.22
YTD Change
-3.38%
1 Year Change
33.78%
Market Cap
120.68M
P/E Ratio
N/A
Volume
13,355
Beta
0.19
Sector
Health Technology
Industry
Pharmaceuticals Major
Economic CalendarAll Events
Time zone: GMT
Thursday, April 18th 2024
Time Currency Event Impact Actual Consensus Previous
14:00

USD
Existing Home SalesMar
Medium
4.19M 4.2M 4.38M
15:00

USD
Fed Bostic Speech
Medium
21:45

USD
Fed Bostic Speech
Medium
Friday, April 19th 2024
Time Currency Event Impact Actual Consensus Previous
14:30

USD
Fed Goolsbee Speech
Medium
Monday, April 22nd 2024
Time Currency Event Impact Actual Consensus Previous
12:30

USD
Chicago Fed National Activity IndexMar
Medium
0.09 0.05
Tuesday, April 23rd 2024
Time Currency Event Impact Actual Consensus Previous
13:45

USD
S&P Global Composite PMI FlashApr
Medium
52.2 52.1
13:45

USD
S&P Global Services PMI FlashApr
Medium
51.8 51.7
Latest News
Seeking AlphaMar 21, 2024
Relmada Therapeutics: Run Up Into Results May Resume Following This Drop
RLMD-6.98%
Seeking AlphaMar 19, 2024
Relmada Therapeutics, Inc. (RLMD) Q4 2023 Earnings Call Transcript
RLMD-6.98%
Seeking AlphaNov 9, 2023
Relmada Therapeutics, Inc. (RLMD) Q3 2023 Earnings Call Transcript
RLMD-6.98%
Seeking AlphaOct 13, 2023
Relmada And REL-1017: Intriguing Underlying Efficacy In MDD Ahead Of Eventful 2024
RLMD-6.98%
Zacks Investment ResearchSep 21, 2023
Relmada (RLMD) Up on Positive Data for Anti-Depressant Candidate
RLMD-6.98%
Seeking AlphaSep 1, 2023
Relmada Therapeutics: Run Up Likely Into Phase 3 Results, Enhanced By Possible Interim Readout
RLMD-6.98%
Read All
Data Vendor:
Stocks
Loading
Loading

Thursday, April 18th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
14:00	USD	Existing Home SalesMar	Medium	4.19M	4.2M	4.38M
15:00	USD	Fed Bostic Speech	Medium
21:45	USD	Fed Bostic Speech	Medium

Friday, April 19th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
14:30	USD	Fed Goolsbee Speech	Medium

Monday, April 22nd 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
12:30	USD	Chicago Fed National Activity IndexMar	Medium		0.09	0.05

Tuesday, April 23rd 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
13:45	USD	S&P Global Composite PMI FlashApr	Medium		52.2	52.1
13:45	USD	S&P Global Services PMI FlashApr	Medium		51.8	51.7

Relmada Therapeutics Inc

Relmada Therapeutics: Run Up Into Results May Resume Following This Drop

Relmada Therapeutics, Inc. (RLMD) Q4 2023 Earnings Call Transcript

Relmada Therapeutics, Inc. (RLMD) Q3 2023 Earnings Call Transcript

Relmada And REL-1017: Intriguing Underlying Efficacy In MDD Ahead Of Eventful 2024

Relmada (RLMD) Up on Positive Data for Anti-Depressant Candidate

Relmada Therapeutics: Run Up Likely Into Phase 3 Results, Enhanced By Possible Interim Readout

Trade With A Regulated Broker